Boots sale agreed with Weston family’s Wittington Investments in $8.9bn deal

Boots is set for a change of ownership after Wittington Investments, the Weston family’s holding company, agreed on Wednesday, 7 October, to buy the UK and Ireland pharmacy chain from Sycamore Partners and the Pessina family. Reuters reported a price of $8.9bn including debt, while the BBC put it at £6.7bn. The agreement matters to customers and staff across a chain that the BBC says has about 1,800 branches and 51,000 employees. The transfer has yet to be completed.

The announcement turns earlier sale talks into an agreed transaction. NewsJaws previously reported the proposed purchase in its article on Boots sale talks with the Weston family; the new development is the agreement announced on Wednesday. The Standard reports that completion is expected in the first quarter of 2027. That timetable is an expectation, not a statement that the new owners have already taken control.

Which Boots businesses are included in the sale?

Wittington’s purchase covers Boots’ retail operations in the UK and Ireland, Boots Opticians, No7 Beauty Company, and the company’s Thailand and franchised businesses, according to Reuters and the BBC. The package therefore reaches beyond the pharmacy shops familiar to UK customers. The reports describe an agreed sale of those businesses; they do not establish a completed handover or set out individual changes for each part of the group.

Sycamore Partners and Stefano Pessina’s family will retain other Boots Group interests rather than selling everything under the group umbrella. Reuters and The Standard identify those retained businesses as Farmacias Benavides in Mexico and Alliance Healthcare Deutschland in Germany. This distinction matters when assessing the reported price: the agreement covers the specified Boots operations and brands, while those two interests are staying with the sellers.

What has Wittington said it plans for Boots?

Reuters says Wittington’s stated plans include investment in stores and online operations and an expansion of healthcare services. Weston described Boots as a business with a vital role in everyday life across the UK and Ireland. He said he saw an opportunity to improve it through long-term ownership, further investment and a renewed focus on operations. These are the buyer’s intentions; the cited reports do not quantify the proposed investment or establish when particular changes would reach customers.

Boots chief executive Alex Baldock also spoke positively about the business after the agreement. The Standard quoted him saying customers and patients trust its capabilities in health, wellness and beauty. That is Baldock’s assessment, rather than evidence that the sale has already changed services. Neither his remarks nor Weston’s amount to a stated commitment in the cited reporting to keep every branch open or maintain a particular staffing level.

Why the change of ownership matters to Boots

The BBC reports that Boots has closed hundreds of UK branches in recent years and now has about 1,800. It links the pressure on the chain to growing debt and changing shopping habits, including customers buying cheaper products online. With 51,000 employees reported by the BBC, decisions about stores and services have a large potential reach. The current reports, however, do not specify which branches or jobs, if any, might be affected by Wittington’s plans.

The buyer comes from a family with substantial retail and pharmacy interests. Reuters identifies the Weston family’s businesses as including Canadian grocer Loblaw and Shoppers Drug Mart, a Canadian pharmacy, health and beauty business. The BBC also says the family is a majority owner of Associated British Foods, the parent of Primark. Those holdings provide context for Wittington’s interest in Boots; they do not, by themselves, establish how Boots will be run after the deal closes.

What remains pending before completion?

The next confirmed milestone in the cited reporting is completion, expected early next year and, more specifically according to The Standard, in the first quarter of 2027. Until then, the announcement remains an agreement to buy the business. The reports do not establish detailed store or job commitments, a quantified investment programme or a timetable for expanding healthcare services. Those questions remain relevant to employees, patients and shoppers as the proposed change of ownership proceeds.